ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type	Tissue	Cell Type	Cell Line	Treatment
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564326	GSE94920	MMTV-PyMT mammary tumors	GSM2491945	Breast Cancer	Invasive Breast Carcinoma (BRCA)	34_L1.N710	None	Mus musculus	34_L1.N710	Breast Cancer	None	Macrophages	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564327	GSE94920	MMTV-PyMT mammary tumors	GSM2491946	Breast Cancer	Invasive Breast Carcinoma (BRCA)	36_L1.N712	None	Mus musculus	36_L1.N712	Breast Cancer	None	CD4+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564328	GSE94920	MMTV-PyMT mammary tumors	GSM2491947	Breast Cancer	Invasive Breast Carcinoma (BRCA)	1_L1	None	Mus musculus	1_L1	Breast Cancer	None	CD31+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564329	GSE94920	MMTV-PyMT mammary tumors	GSM2491948	Breast Cancer	Invasive Breast Carcinoma (BRCA)	29_L1.N705	None	Mus musculus	29_L1.N705	Breast Cancer	None	CD31+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564330	GSE94920	MMTV-PyMT mammary tumors	GSM2491949	Breast Cancer	Invasive Breast Carcinoma (BRCA)	61_L1.N712	None	Mus musculus	61_L1.N712	Breast Cancer	None	CD31+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564331	GSE94920	MMTV-PyMT mammary tumors	GSM2491950	Breast Cancer	Invasive Breast Carcinoma (BRCA)	13_L1.N701	None	Mus musculus	13_L1.N701	Breast Cancer	None	CD31+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564332	GSE94920	MMTV-PyMT mammary tumors	GSM2491951	Breast Cancer	Invasive Breast Carcinoma (BRCA)	49_L1.N701	None	Mus musculus	49_L1.N701	Breast Cancer	None	CD31+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564333	GSE94920	MMTV-PyMT mammary tumors	GSM2491952	Breast Cancer	Invasive Breast Carcinoma (BRCA)	17_L1	None	Mus musculus	17_L1	Breast Cancer	None	CD31+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564334	GSE94920	MMTV-PyMT mammary tumors	GSM2491953	Breast Cancer	Invasive Breast Carcinoma (BRCA)	15_L1.N703	None	Mus musculus	15_L1.N703	Breast Cancer	None	CD8+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564335	GSE94920	MMTV-PyMT mammary tumors	GSM2491954	Breast Cancer	Invasive Breast Carcinoma (BRCA)	63_L5	None	Mus musculus	63_L5	Breast Cancer	None	CD8+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564336	GSE94920	MMTV-PyMT mammary tumors	GSM2491955	Breast Cancer	Invasive Breast Carcinoma (BRCA)	64_L1.N703	None	Mus musculus	64_L1.N703	Breast Cancer	None	CD4+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564337	GSE94920	MMTV-PyMT mammary tumors	GSM2491956	Breast Cancer	Invasive Breast Carcinoma (BRCA)	3_L1.N703	None	Mus musculus	3_L1.N703	Breast Cancer	None	CD8+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564338	GSE94920	MMTV-PyMT mammary tumors	GSM2491957	Breast Cancer	Invasive Breast Carcinoma (BRCA)	51_L1.N703	None	Mus musculus	51_L1.N703	Breast Cancer	None	CD8+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564339	GSE94920	MMTV-PyMT mammary tumors	GSM2491958	Breast Cancer	Invasive Breast Carcinoma (BRCA)	33_L1.N709	None	Mus musculus	33_L1.N709	Breast Cancer	None	CD31+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564340	GSE94920	MMTV-PyMT mammary tumors	GSM2491959	Breast Cancer	Invasive Breast Carcinoma (BRCA)	52_L1.N704	None	Mus musculus	52_L1.N704	Breast Cancer	None	CD4+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564341	GSE94920	MMTV-PyMT mammary tumors	GSM2491960	Breast Cancer	Invasive Breast Carcinoma (BRCA)	20_L2	None	Mus musculus	20_L2	Breast Cancer	None	CD4+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564342	GSE94920	MMTV-PyMT mammary tumors	GSM2491961	Breast Cancer	Invasive Breast Carcinoma (BRCA)	4_L3	None	Mus musculus	4_L3	Breast Cancer	None	CD4+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564343	GSE94920	MMTV-PyMT mammary tumors	GSM2491962	Breast Cancer	Invasive Breast Carcinoma (BRCA)	14_L1.N702	None	Mus musculus	14_L1.N702	Breast Cancer	None	Macrophages	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564344	GSE94920	MMTV-PyMT mammary tumors	GSM2491963	Breast Cancer	Invasive Breast Carcinoma (BRCA)	45_L1.N709	None	Mus musculus	45_L1.N709	Breast Cancer	None	CD31+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564345	GSE94920	MMTV-PyMT mammary tumors	GSM2491964	Breast Cancer	Invasive Breast Carcinoma (BRCA)	19_L1	None	Mus musculus	19_L1	Breast Cancer	None	CD8+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564346	GSE94920	MMTV-PyMT mammary tumors	GSM2491965	Breast Cancer	Invasive Breast Carcinoma (BRCA)	2_L2	None	Mus musculus	2_L2	Breast Cancer	None	Macrophages	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564347	GSE94920	MMTV-PyMT mammary tumors	GSM2491966	Breast Cancer	Invasive Breast Carcinoma (BRCA)	18_L2	None	Mus musculus	18_L2	Breast Cancer	None	Macrophages	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564348	GSE94920	MMTV-PyMT mammary tumors	GSM2491967	Breast Cancer	Invasive Breast Carcinoma (BRCA)	16_L1.N704	None	Mus musculus	16_L1.N704	Breast Cancer	None	CD4+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564349	GSE94920	MMTV-PyMT mammary tumors	GSM2491968	Breast Cancer	Invasive Breast Carcinoma (BRCA)	30_L1.N706	None	Mus musculus	30_L1.N706	Breast Cancer	None	Macrophages	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564350	GSE94920	MMTV-PyMT mammary tumors	GSM2491969	Breast Cancer	Invasive Breast Carcinoma (BRCA)	35_L1.N711	None	Mus musculus	35_L1.N711	Breast Cancer	None	CD8+ cells	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564351	GSE94920	MMTV-PyMT mammary tumors	GSM2491970	Breast Cancer	Invasive Breast Carcinoma (BRCA)	32_L1.N708	None	Mus musculus	32_L1.N708	Breast Cancer	None	CD4+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564352	GSE94920	MMTV-PyMT mammary tumors	GSM2491971	Breast Cancer	Invasive Breast Carcinoma (BRCA)	50_L1.N702	None	Mus musculus	50_L1.N702	Breast Cancer	None	Macrophages	None	A2V
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564353	GSE94920	MMTV-PyMT mammary tumors	GSM2491972	Breast Cancer	Invasive Breast Carcinoma (BRCA)	31_L1.N707	None	Mus musculus	31_L1.N707	Breast Cancer	None	CD8+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564354	GSE94920	MMTV-PyMT mammary tumors	GSM2491973	Breast Cancer	Invasive Breast Carcinoma (BRCA)	46_L1.N710	None	Mus musculus	46_L1.N710	Breast Cancer	None	Macrophages	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564355	GSE94920	MMTV-PyMT mammary tumors	GSM2491974	Breast Cancer	Invasive Breast Carcinoma (BRCA)	62_L4	None	Mus musculus	62_L4	Breast Cancer	None	Macrophages	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564356	GSE94920	MMTV-PyMT mammary tumors	GSM2491975	Breast Cancer	Invasive Breast Carcinoma (BRCA)	47_L1.N711	None	Mus musculus	47_L1.N711	Breast Cancer	None	CD8+ cells	None	IgG
GSE94920	28404865	Dual angiopoietin-2 and VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 checkpoint blockade	None	SRX2564357	GSE94920	MMTV-PyMT mammary tumors	GSM2491976	Breast Cancer	Invasive Breast Carcinoma (BRCA)	48_L1.N701_502	None	Mus musculus	48_L1.N701_502	Breast Cancer	None	CD4+ cells	None	IgG
